We serve Chemical Name:3,4-dimethoxy-2-propan-2-ylbenzaldehyde CAS:77256-02-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:3,4-dimethoxy-2-propan-2-ylbenzaldehyde
CAS.NO:77256-02-1
Synonyms:Benzaldehyde,3,4-dimethoxy-2-(1-methylethyl);2-Isopropyl-3,4-dimethoxybenzaldehyde;2-Isopropyl-3,4-dimethoxy-benzaldehyd
Molecular Formula:C12H16O3
Molecular Weight:208.25400
HS Code:2912499000
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:35.53000
Exact Mass:208.11000
LogP:2.63970
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like Benzaldehyde,3,4-dimethoxy-2-(1-methylethyl) chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Isopropyl-3,4-dimethoxy-benzaldehyd physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Benzaldehyde,3,4-dimethoxy-2-(1-methylethyl) Use and application,2-Isopropyl-3,4-dimethoxybenzaldehyde technical grade,usp/ep/jp grade.
Related News: The victim — who died Saturday — was a 44-year-Chinese man who flew in from Wuhan in January. 3,4-dimethoxy-2-propan-2-ylbenzaldehyde manufacturer ViiV, in which Pfizer and Shionogi have small stakes, said it received a so-called complete response letter (CRL) from the FDA in which the regulator questioned the treatment��s chemistry, manufacturing and controls process, but not its safety. 3,4-dimethoxy-2-propan-2-ylbenzaldehyde supplier If the Justice Department concludes that an internal investigation was thorough, it can result in a non-prosecution agreement with few, if any, penalties, the experts said. However, a company-led investigation that appears to have been poorly handled could lead to harsher outcomes. 3,4-dimethoxy-2-propan-2-ylbenzaldehyde vendor Additional results from the trial with data on another goal of extending survival is expected in 2020, AstraZeneca said. 3,4-dimethoxy-2-propan-2-ylbenzaldehyde factory Additional results from the trial with data on another goal of extending survival is expected in 2020, AstraZeneca said.
